Disease Info Card

Tuberculosis, Multidrug-resistant

Information about Tuberculosis, Multidrug-resistant: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Tuberculosis, Multidrug-resistant

Most recent studies have shown that Tuberculosis, Multidrug-resistant shares some biological mechanisms with acquired-immunodeficiency-syndrome, active-tuberculosis, aids-related-opportunistic-infections, coinfection, communicable-diseases, coughing, cross-infection, drug-resistant-tuberculosis, extensively-drug-resistant-tuberculosis, hiv-infections, immunologic-deficiency-syndromes, infective-disorder, latent-tuberculosis, lung-diseases, meningitis, mycobacterium-infections, tuberculosis, tuberculosis-meningeal, tuberculosis-pulmonary, virus-diseases.

Among the many pathways, these few ones have gauged particular interests from scientists studying Tuberculosis, Multidrug-resistant, and have been seen in publications frequently: Aging, Coagulation, Cytokine Production, Dna Amplification, Dna Repair, Drug Resistance, Excretion, Flight, Hypersensitivity, Immune Response, Inflammatory Response, Leukocyte Activation, Localization, Pathogenesis, Pigmentation, Reverse Transcription, Secretion, Transport, Transposition, Virulence

Quite a number of genes have been found to play important roles in Tuberculosis, Multidrug-resistant, such as ABCA4, CAT, CD4, DST, EMB, FPR2, GNA12, IL10, IL2, INHA, NCAPG2, RHOF, RNF34, TNF, TOP2A, TRIM27, URI1, XPO1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.